Prospective Observational Study Based on a Cohort of Geriatric Patients With Hip Fracture Treated in the Centers Belonging to the GIOG Group
NCT ID: NCT05150249
Last Updated: 2025-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
7000 participants
OBSERVATIONAL
2019-07-15
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ProspEctive Cohort Study on Multidisciplinary Approach to Femur FRactures' manAgement in Over 65 Population
NCT04127045
Geriatric Fracture Centers - Evaluation of a Geriatric Co-management Program
NCT02297581
Institutional Registry of Hip Fracture in the Elderly
NCT02279550
Study of Parameters of Osteosarcopenia in Patients With Hip Fracture
NCT04730622
Observational Clinical Study on Elderly Patients With Fracture of the Proximal Femur Treated With the Chimaera Nail
NCT05197335
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* High intensity: continuous data collection for the whole period of the study on all the incident cases
* Low intensity: data collection once a year on incident cases over a continuous period of 1 month, with a reduced number of variables.
The choice of the level of intensity with regard to the data collection method will take place on a voluntary basis (each OU will actually choose the type of speed with which it intends to collaborate in the project, after communicating to the steering committee and to the biostatisticians of the study)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 65 years
* Willingness to participate in the study by the patient or a relative / caregiver, if the patient is unable to understand and is not "competent" at the time of the evaluation.
* Able to speak the Italian language
Exclusion Criteria
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Milano Bicocca
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ospedale S. Agostino Estense
Baggiovara, , Italy
Policlinico S.Orsola-Malpighi
Bologna, , Italy
Ospedale Centrale di Bolzano
Bolzano, , Italy
ASST Vimercate - Ospedale di Carate Brianza
Carate Brianza, , Italy
Arcispedale Sant'Anna
Ferrara, , Italy
A.O.U. di Careggi
Florence, , Italy
Azienda Usl Toscana centro
Florence, , Italy
Ospedale Galliera Genova
Genova, , Italy
Ospedale Policlinico S. Martino
Genova, , Italy
Policlinico Universitario Campus Bio-Medico
Roma, , Italy
ASST della Valtellina e dell'Alto Lario
Sondrio, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Giuseppe Castoldi
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GIOG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.